Cargando…

Pathologic Factors Associated with Prognosis after Adjuvant Chemotherapy in Stage II/III Microsatellite-Unstable Colorectal Cancers

BACKGROUND: Although there are controversies regarding the benefit of fluoropyrimidine-based adjuvant chemotherapy in patients with microsatellite instability–high (MSI-H) colorectal cancer (CRC), the pathologic features affecting postchemotherapeutic prognosis in these patients have not been fully...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jung Ho, Bae, Jeong Mo, Oh, Hyeon Jeong, Lee, Hye Seung, Kang, Gyeong Hoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Pathologists and the Korean Society for Cytopathology 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367107/ https://www.ncbi.nlm.nih.gov/pubmed/26148739 http://dx.doi.org/10.4132/jptm.2015.02.05

Ejemplares similares

Prognostic Impact of Fusobacterium nucleatum Depends on Combined Tumor Location and Microsatellite Instability Status in Stage II/III Colorectal Cancers Treated with Adjuvant Chemotherapy
por: Oh, Hyeon Jeong, et al.
Publicado: (2019)

Differential Features of Microsatellite-Unstable Colorectal Carcinomas Depending on EPCAM Expression Status
por: Kim, Jung Ho, et al.
Publicado: (2014)

Characterisation of PD-L1-positive subsets of microsatellite-unstable colorectal cancers
por: Kim, Jung Ho, et al.
Publicado: (2016)

Genomic and transcriptomic characterization of heterogeneous immune subgroups of microsatellite instability-high colorectal cancers
por: Kim, Jung Ho, et al.
Publicado: (2021)

p53 expression status is associated with cancer-specific survival in stage III and high-risk stage II colorectal cancer patients treated with oxaliplatin-based adjuvant chemotherapy
por: Oh, Hyeon Jeong, et al.
Publicado: (2019)

Tumor microenvironment-adjusted prognostic implications of the KRAS mutation subtype in patients with stage III colorectal cancer treated with adjuvant FOLFOX
por: Park, Hye Eun, et al.
Publicado: (2021)

Association of pathway mutation with survival after recurrence in colorectal cancer patients treated with adjuvant fluoropyrimidine and oxaliplatin chemotherapy
por: Lee, Dae-Won, et al.
Publicado: (2019)

The CpG island methylator phenotype may confer a survival benefit in patients with stage II or III colorectal carcinomas receiving fluoropyrimidine-based adjuvant chemotherapy
por: Min, Byung-Hoon, et al.
Publicado: (2011)

Molecular genetics of microsatellite-unstable colorectal cancer for pathologists
por: Chen, Wei, et al.
Publicado: (2017)

N-Glycomic Profiling of Microsatellite Unstable Colorectal Cancer
por: Ukkola, Iiris, et al.
Publicado: (2023)

Targeted next-generation sequencing-based detection of microsatellite instability in colorectal carcinomas
por: Lee, Yunbeom, et al.
Publicado: (2021)

Prognosis and Sensitivity of Adjuvant Chemotherapy in Mucinous Colorectal Adenocarcinoma without Distant Metastasis
por: Bong, Jun-Woo, et al.
Publicado: (2022)

SnoN expression is differently regulated in microsatellite unstable compared with microsatellite stable colorectal cancers
por: Chia, June A, et al.
Publicado: (2006)

Adjuvant Chemotherapy in Microsatellite Instability–High Gastric Cancer
por: Kim, Jin Won, et al.
Publicado: (2020)

Prognosis of stage III colorectal carcinomas with FOLFOX adjuvant chemotherapy can be predicted by molecular subtype
por: Kwon, Yujin, et al.
Publicado: (2017)

Overexpression of POSTN in Tumor Stroma Is a Poor Prognostic Indicator of Colorectal Cancer
por: Oh, Hyeon Jeong, et al.
Publicado: (2017)

Combined prognostic effect of PD-L1 expression and immunoscore in microsatellite-unstable advanced gastric cancers
por: Kim, Kyung-Ju, et al.
Publicado: (2017)

Clinico-pathologic Parameters for Prediction of Microsatellite Instability in Colorectal Cancer
por: Jung, Sang-Bong, et al.
Publicado: (2012)

Immune landscape and biomarkers for immuno-oncology in colorectal cancers
por: Bae, Jeong Mo, et al.
Publicado: (2020)

The immune biology of microsatellite unstable cancer
por: von Knebel-Doeberitz, Magnus
Publicado: (2010)

Most microsatellite unstable sporadic colorectal carcinomas carry MBD4 mutations
por: Bader, S, et al.
Publicado: (2000)

The Different Roles of hRAD50 in Microsatellite Stable and Unstable Colorectal Cancers
por: Gao, Jingfang, et al.
Publicado: (2008)

Comprehensive evaluation of coding region point mutations in microsatellite‐unstable colorectal cancer
por: Kondelin, Johanna, et al.
Publicado: (2018)

Tumor Infiltrating Lymphocytes and Macrophages Improve Survival in Microsatellite Unstable Colorectal Cancer
por: Narayanan, Sumana, et al.
Publicado: (2019)

Differences in prognosis and underuse of adjuvant chemotherapy between elderly and non‐elderly patients in stage III colorectal cancer
por: Shiraishi, Takuya, et al.
Publicado: (2022)

Clinicopathologic, molecular, and prognostic implications of the loss of EPCAM expression in colorectal carcinoma
por: Kim, Jung Ho, et al.
Publicado: (2015)

Multiplicity of Advanced T Category–Tumors Is a Risk Factor for Survival in Patients with Colorectal Carcinoma
por: Park, Hye Eun, et al.
Publicado: (2018)

mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer
por: Lanza, Giovanni, et al.
Publicado: (2007)

Colorectal carcinomas in MUTYH-associated polyposis display histopathological similarities to microsatellite unstable carcinomas
por: Nielsen, Maartje, et al.
Publicado: (2009)

Regulatory T Lymphocytes Are Associated with Less Aggressive Histologic Features in Microsatellite-Unstable Colorectal Cancers
por: Tougeron, David, et al.
Publicado: (2013)

Prognostic influence of body mass index and body weight gain during adjuvant FOLFOX chemotherapy in Korean colorectal cancer patients
por: Lee, Dae-Won, et al.
Publicado: (2015)

Prognostic Significance of EPHB2 Expression in Colorectal Cancer Progression
por: Jang, Bo Gun, et al.
Publicado: (2018)

The impact of chemotherapy-associated neutrophil/ lymphocyte counts on prognosis of adjuvant chemotherapy in colorectal cancer
por: Chu-Yuan, Hong, et al.
Publicado: (2013)

Differences in prognosis by p53 expression after neoadjuvant chemotherapy in triple-negative breast cancer
por: Bae, Soo Youn, et al.
Publicado: (2020)

Clustered 8-Oxo-Guanine Mutations and Oncogenic Gene Fusions in Microsatellite-Unstable Colorectal Cancer
por: Madison, Russell W., et al.
Publicado: (2022)

Effect of adjuvant chemotherapy after pulmonary metastasectomy on the prognosis of colorectal cancer
por: Shiomi, Kazu, et al.
Publicado: (2017)

The Prognosis and the Role of Adjuvant Chemotherapy for Node-Positive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by Surgery
por: Jeong, Hyehyun, et al.
Publicado: (2022)

Nutritional status predicts adjuvant chemotherapy outcomes for stage III colorectal cancer
por: Ihara, Keisuke, et al.
Publicado: (2019)

Different prognostic effect of CpG island methylation according to sex in colorectal cancer patients treated with adjuvant FOLFOX
por: Lee, Dae-Won, et al.
Publicado: (2015)

Microsatellite Instability of Gastric and Colorectal Cancers as a Predictor of Synchronous Gastric or Colorectal Neoplasms
por: Kim, Young Beak, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_grcd698ailmocphlc90rmbn2eb